BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 30246736)

  • 1. Diffuse Pulmonary Alveolar Hemorrhage Secondary to All-Trans-Retinoic Acid in Acute Promyelocytic Leukemia.
    Yang CL; Shen K; Huang J
    Chin Med J (Engl); 2018 Oct; 131(19):2386-2387. PubMed ID: 30246736
    [No Abstract]   [Full Text] [Related]  

  • 2. First report of successful management of acute promyelocytic leukemia in a pregnant female with All-Trans-Retinoic Acid and Arsenic Trioxide-based induction regimen.
    Khosla H; Jain A; Tatawadiya S; Prasad P; Nagpal K; Chaudhry S; Sharma M; Gupta DK; Saluja S; Jain A
    Blood Cells Mol Dis; 2020 Nov; 85():102476. PubMed ID: 32688220
    [No Abstract]   [Full Text] [Related]  

  • 3. Real world data with concurrent retinoic acid and arsenic trioxide for the treatment of acute promyelocytic leukemia.
    Kulkarni UP; Selvarajan S; Lionel S; Prakash MA; Palani HK; Balasundaram N; Venkataraman A; Korula A; Devasia AJ; Fouzia NA; Janet NB; Nair SC; Abraham A; Mani T; Lakshmanan J; Arunachalam AK; Balasubramanian P; George B; Mathews V
    Blood Cancer J; 2022 Jan; 12(1):22. PubMed ID: 35102152
    [No Abstract]   [Full Text] [Related]  

  • 4. Arsenic and all-
    Levis M
    Haematologica; 2021 Dec; 106(12):3031-3032. PubMed ID: 34047181
    [No Abstract]   [Full Text] [Related]  

  • 5. Switching from all-trans retinoic acid to arsenic trioxide for newly diagnosed acute promyelocytic leukemia.
    Imagawa J
    Leuk Lymphoma; 2018 Dec; 59(12):3013-3015. PubMed ID: 29616847
    [No Abstract]   [Full Text] [Related]  

  • 6. The impact of oral arsenic and all-trans-retinoic acid on coagulopathy in acute promyelocytic leukemia.
    Zhu HH; Guo ZP; Jia JS; Jiang Q; Jiang H; Huang XJ
    Leuk Res; 2018 Feb; 65():14-19. PubMed ID: 29232592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acute Promyelocytic Leukemia: New treatment strategies with ATRA and ATO - AML-BFM-Recommendations].
    Creutzig U; Dworzak M; von Neuhoff N; Rasche M; Reinhardt D
    Klin Padiatr; 2018 Oct; 230(6):299-304. PubMed ID: 30399642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [State-of-the-art treatment of acute promyelocytic leukemia].
    Kiguchi T
    Rinsho Ketsueki; 2018; 59(10):2007-2018. PubMed ID: 30305503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Therapeutically Related Drugs on Coagulation-Anticoagulation Balance in Acute Promyelocytic Leukemia.
    Xiao M; Zhou P; Sun K
    Clin Appl Thromb Hemost; 2022; 28():10760296221080166. PubMed ID: 35187963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Successful treatment of acute promyelocytic leukaemia without chemotherapy and blood transfusion].
    Tøstesen M; Østgård LSG; Kjeldsen E; Stentoft J; Nørgaard JM
    Ugeskr Laeger; 2018 Jan; 180(3):. PubMed ID: 29336300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acute promyelocytic leukemia: state-of-the-art management].
    Asou N
    Rinsho Ketsueki; 2018; 59(6):725-734. PubMed ID: 29973452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acute promyelocytic leukaemia].
    Tøstesen M; Østergård LSG; Kjeldsen E; Stentoft J; Nørgaard JM
    Ugeskr Laeger; 2018 Jan; 180(3):. PubMed ID: 29336301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flexural Eruption Associated With Arsenic Trioxide Therapy in a Patient With Acute Promyelocytic Leukemia.
    Teran VA; Wilson BB; Guffey DJ
    JAMA Dermatol; 2019 Mar; 155(3):389-391. PubMed ID: 30673070
    [No Abstract]   [Full Text] [Related]  

  • 14. CPSF6-RARG-positive acute myeloid leukaemia resembles acute promyelocytic leukaemia but is insensitive to retinoic acid and arsenic trioxide.
    Li J; Yan WZ; Bai LH; Jiang YF; Peng HL; Shen JK; Li RJ
    Pathology; 2023 Apr; 55(3):407-412. PubMed ID: 36241556
    [No Abstract]   [Full Text] [Related]  

  • 15. Retinoic acid syndrome induced by arsenic trioxide in treating recurrent all-trans retinoic acid resistant acute promyelocytic leukemia.
    Che-Pin Lin ; Huang MJ; Chang IY; Lin WY; Sheu YT
    Leuk Lymphoma; 2000 Jun; 38(1-2):195-8. PubMed ID: 10811463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addition of Arsenic Trioxide into Induction Regimens Could Not Accelerate Recovery of Abnormality of Coagulation and Fibrinolysis in Patients with Acute Promyelocytic Leukemia.
    Zhang Y; Wu S; Luo D; Zhou J; Li D
    PLoS One; 2016; 11(1):e0147545. PubMed ID: 26812490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffuse alveolar hemorrhage in acute promyelocytic leukemia patients treated with ATRA--a manifestation of the basic disease or the treatment.
    Raanani P; Segal E; Levi I; Bercowicz M; Berkenstat H; Avigdor A; Perel A; Ben-Bassat I
    Leuk Lymphoma; 2000 May; 37(5-6):605-10. PubMed ID: 11042521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of acute promyelocytic leukemia in pregnancy with single-agent all-trans retinoic acid.
    Nellessen CM; Janzen V; Mayer K; Giovannini G; Gembruch U; Brossart P; Merz WM
    Arch Gynecol Obstet; 2018 Feb; 297(2):281-284. PubMed ID: 29110117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. All-trans-retinoic acid and arsenic trioxide as initial therapy for acute promyelocytic leukemia.
    Quezada G; Kopp L; Estey E; Wells RJ
    Pediatr Blood Cancer; 2008 Jul; 51(1):133-5. PubMed ID: 18293388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute Promyelocytic Leukemia.
    Winkler C
    N Engl J Med; 2024 May; 390(17):e42. PubMed ID: 38683728
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.